Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd [2012] FCA 412 (23 April 2012)
Practice and procedure – interlocutory injunction – whether application for leave to appeal should be referred to a Full Court
Generic Health Pty Ltd will have the opportunity to appeal the decision of a single judge of the Federal Court of Australia granting a preliminary injunction preventing it from launching a generic version of the antipsychotic drug ABILIFY (see Australian Federal Court Blocks Generic ABILIFY (Aripiprazole)).
In general, any decision of a single judge of the Federal Court can be challenged by appeal to the Full Court – a panel of three judges. In the case of a final ruling, i.e. after a full trial, any party to the proceedings automatically has the right to appeal. However, a Full Court review of a preliminary judgement requires permission, i.e. ‘leave’ to appeal.
As a result, appealing a preliminary injunction is generally a two-step process – first the appellant must obtain leave to take the matter to a Full Bench of the court and then, if leave is granted, it is still necessary for the appeal proper to be heard.
In this case, Justice Katzmann has granted a request by Generic Health for its application for leave to be heard by a Full Bench of the court, and for the appeal itself to be heard either simultaneously, or immediately following the leave hearing. Regular readers of this blog may recall that Justice Foster made a similar ruling in favour of Samsung last year (see Samsung Over First Hurdle in Bid To Overturn Apple Injunction).
Practice and procedure – interlocutory injunction – whether application for leave to appeal should be referred to a Full Court
In general, any decision of a single judge of the Federal Court can be challenged by appeal to the Full Court – a panel of three judges. In the case of a final ruling, i.e. after a full trial, any party to the proceedings automatically has the right to appeal. However, a Full Court review of a preliminary judgement requires permission, i.e. ‘leave’ to appeal.
As a result, appealing a preliminary injunction is generally a two-step process – first the appellant must obtain leave to take the matter to a Full Bench of the court and then, if leave is granted, it is still necessary for the appeal proper to be heard.
In this case, Justice Katzmann has granted a request by Generic Health for its application for leave to be heard by a Full Bench of the court, and for the appeal itself to be heard either simultaneously, or immediately following the leave hearing. Regular readers of this blog may recall that Justice Foster made a similar ruling in favour of Samsung last year (see Samsung Over First Hurdle in Bid To Overturn Apple Injunction).
